Not at all true (at least not for all pharma, perhaps it is more true for the larger pharmaceuticals, but there are plenty of smaller ones that work on cures... like mine). This treatment would be pharma's dream anyway. The nanoparticle would need to be continuously taken to prevent the amyloid beta from re-aggregating. That has all the signs of making profits.